I discuss some central ideas of the enactive approach in cognitive science, including the concepts of autonomy, sense-making, and agency, and show the way they are grounded in dynamical systems theory, organizational approaches to biology, and phenomenology. I highlight known and potentially new connections between enactive cognitive science and dynamical and relational perspectives on human development. Taking the notion of sensorimotor know-how or mastery as a particular case, I describe a dynamical formalization of Piaget’s theory of equilibration that serves to clarify this notion. The dynamical interpretation also lays the groundwork for a novel concept of sensorimotor agency based on self-sustaining networked relations between sensorimotor schemes. Some of the tools that are used in fleshing out this idea, such as a network representation of sensorimotor repertoires, can be of use for clarifying the processes that underlie developmental variability, apparent developmental jumps, and the role of socially induced disequilibrium in enabling developmental change during adult-infant interactions. The exercise serves to clarify the ontological and epistemological commitments of enactive theory.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.